A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
Active, not recruiting · NCT05743881 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months | Human Metapneumovirus; Respiratory Syncytial Virus | Active, not recruiting | Phase 1 | 2026-06-26 | NCT05743881 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ModernaTX, Inc. | 41 |
17 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CEVAXIN 24 de Diciembre | Panama City | Panama | 2 |
| CEVAXIN Avenida Mexico | Panama City | Panama | 1 |
| CEVAXIN Chorrera | La Chorrera | Panama | 1 |
| CEVAXIN David | David | Panama | 1 |
| CyFair | Houston | United States | 1 |
| DM Clinical Research- River Forest | Melrose Park | United States | 1 |
| Duke Vaccine and Trials Unit | Durham | United States | 12 |
| Matrix Clinical Research | Los Angeles | United States | 5 |
| MedPharmics - Platinum - PPDS | Lafayette | United States | 1 |
| Meridian Clinical Research | Washington D.C. | United States | 1 |
| Norfolk and Norwich University Hospitals | Norwich | United Kingdom | 1 |
| Palmetto Pediatrics, PA | North Charleston | United States | 1 |
| Pediatric Associates | Houston | United States | 2 |
| Pediatric Center | Richmond | United States | 1 |
| Vanderbilt Vaccine Research Program | Nashville | United States | 2 |
| Velocity Clinical Research - Providence | Providence | United States | 1 |
| Village Pediatrics | Plano | United States | 1 |